Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North
P.O. Box 19024
Tel: (206) 667-4700
178 articles with Fred Hutchinson Cancer Research Center
Alkermes Announces Clinical Collaboration With Fred Hutchinson Cancer Research Center for Novel Immuno-Oncology Drug Candidate ALKS 4230
Planned Phase 2 Multi-Site Trial to Evaluate ALKS 4230 in Combination With Pembrolizumab in Patients With Advanced or Recurrent Head and Neck Squamous Cell Cancer
ElevateBio Launches HighPassBio to Advance Novel Targeted T Cell Immunotherapies with Technology from Fred Hutchinson Cancer Research Center
T cell receptor (TCR) T cell therapy targeting HA-1 expressing tumors designed to manage post-hematopoietic stem cell transplant leukemic relapse
Hyundai Hope On Wheels Presents Fred Hutchinson Cancer Research Center With $300,000 Hyundai Scholar Hope Grant To Support Pediatric Cancer Research
The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research. [24-September-2019] SEATTLE , Sept. 24, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyun
Fred Hutchinson Cancer Research Center and Leica Microsystems Establish Center of Excellence in Microscopy
Fred Hutchinson Cancer Research Center and Leica Microsystems, Inc. have combined efforts to establish the Leica Microsystems Center of Excellence at Fred Hutch.
EpiCypher® announces the launch of CUTANA™ (ChIC / CUT&RUN / CUT&Tag) for next-generation genomic mapping studies
EpiCypher, Inc. announces the commercial licensing of ChIC (University of Geneva) and CUT&RUN / CUT&Tag (Fred Hutchinson Cancer Research Center) technologies.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.
January 25 Research Roundup: Alzheimer’s Memory Recovery and Testing, New Antibiotics, Possible S...
1/25/2019There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
10/22/2018The U.S. Bureau of Labor Statistics predicts a 7 percent increase in jobs for biomedical engineers and a 13 percent increase in medical scientists.
GO Therapeutics, headquartered in Cambridge, Mass., signed a licensing deal with Swiss-based Roche to develop antibodies for cancer.
Some cancer cells have a remarkable and frightening sense of self-preservation to avoid immunotherapy treatments. That is the finding from a new study conducted by researchers at the Fred Hutchinson Cancer Research Center in Seattle.
By many standards, and certainly by the way the media covers it and industry promotes it, immuno-oncology therapies using CAR-T are revolutionizing cancer treatments. But what if, as the saying goes, they threw a revolution and nobody came? Or more precisely, what if they threw a revolution and n...
Evotec Forms Academic Bridge 'LAB591' with Arix Bioscience and Fred Hutchinson Cancer Research Center
Initial term of LAB591 is five years.
ACEA Biosciences, a biotechnology company that develops high performance cell analysis instruments, hosted their 6th annual Cancer Immunotherapy Symposium focused on CAR-T cell and TCR therapy on April 14, 2018 at the W Hotel in Chicago, prior to the 2018 AACR Annual Meeting.
Trianni Signs Collaboration Agreement With Fred Hutchinson Cancer Research Center For Use Of The Trianni Mouse Platform
10X Genomics Release: Company Announces Publication Of Study In Nature Communications Demonstrating Single Cell Profiling In Leukemia Patients By The Fred Hutchinson Cancer Research Center
Study Conducted At Fred Hutchinson Cancer Research Center Shows Transplant Patients Benefit From Glytec LLC's System For Computer-Guided Glucose Management
Fred Hutchinson Cancer Research Center Appoints FY 2016-17 Board Members, Including Microsoft CEO Satya Nadella
Juno and Blaze Bioscience's Success Inspires Fred Hutchinson Cancer Research Center to Spin Out More Companies Faster